Expert Opinion on Therapeutic Targets

Papers
(The H4-Index of Expert Opinion on Therapeutic Targets is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma110
TGF-beta: a master immune regulator101
TRPA1 as a therapeutic target for nociceptive pain93
The cytokine storm of COVID-19: a spotlight on prevention and protection77
Esophageal cancer: emerging therapeutics51
Therapeutic antibodies and fusion inhibitors targeting the spike protein of SARS-CoV-249
Cancer associated fibroblasts: role in breast cancer and potential as therapeutic targets42
New therapeutic targets in chronic kidney disease progression and renal fibrosis40
Aberrations of DNA repair pathways in prostate cancer: a cornerstone of precision oncology39
Macrophage polarization: an effective approach to targeted therapy of inflammatory bowel disease35
Glioblastoma multiforme: novel therapeutic targets35
Targeting TLR4-dependent inflammation in post-hemorrhagic brain injury33
TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-233
The SHH/GLI signaling pathway: a therapeutic target for medulloblastoma33
Omentin-1: a newly discovered warrior against metabolic related diseases33
Nutritional intervention in chronic pain: an innovative way of targeting central nervous system sensitization?33
HSP47: a potential target for fibrotic diseases and implications for therapy30
Duodenal inflammation: an emerging target for functional dyspepsia?29
CCR5 is a potential therapeutic target for cancer28
Using sigma-ligands as part of a multi-receptor approach to target diseases of the brain28
The role of microRNA in cisplatin resistance or sensitivity26
Drugs that offer the potential to reduce hospitalization and mortality from SARS-CoV-2 infection: The possible role of the sigma-1 receptor and autophagy26
ERAP1: a potential therapeutic target for a myriad of diseases26
Cysteine cathepsins as therapeutic targets in inflammatory diseases25
Targeting TANK-binding kinase 1 (TBK1) in cancer25
0.025602102279663